within Pharmacolibrary.Drugs.ATC.A;

model A12CC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 370 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A12CC08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Magnesium pidolate is a magnesium salt of pidolic acid, used as an oral magnesium supplement. It is indicated in the treatment and prevention of magnesium deficiency, which may manifest as muscle cramps, fatigue, irritability, or cardiac symptoms. It is available over-the-counter in several European countries, but is not widely used or approved in the United States.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with detailed compartmental parameters found for magnesium pidolate in humans. Estimates below are based on pharmacokinetic literature for oral magnesium salts in adults.</p><h4>References</h4><ol><li><p>Maier, JA, Pickering, G, Giacomoni, E, Cazzaniga, A, &amp; Pellegrino, P (2020). Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. <i>Nutrients</i> 12(9) –. DOI:<a href=\"https://doi.org/10.3390/nu12092660\">10.3390/nu12092660</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32878232/\">https://pubmed.ncbi.nlm.nih.gov/32878232</a></p></li><li><p>Zhang, R, Qiu, M, Zhao, L, Cui, L, Wang, C, Zhu, J, &amp; Hao, Z (2018). Pharmacokinetics of pidotimod in broiler chickens by UHPLC-MS/MS after oral and intravenous administration. <i>Biomedical chromatography : BMC</i> 32(3) –. DOI:<a href=\"https://doi.org/10.1002/bmc.4130\">10.1002/bmc.4130</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29105801/\">https://pubmed.ncbi.nlm.nih.gov/29105801</a></p></li><li><p>Mailland, F, Coppi, G, &amp; Silingardi, S (1994). Pharmacokinetics and oral bioavailability of pidotimod in humans. <i>Arzneimittel-Forschung</i> 44(12A) 1465–1469. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7857343/\">https://pubmed.ncbi.nlm.nih.gov/7857343</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A12CC08;
